Follow-up after intravitreal triamcinolone acetonide for diabetic macular edema

European Journal of Ophthalmology

Volumn 16, Issue 4, 2006, Pages 566-572

  Jonas, Jost B ^a,b   Spandau, U H ^a   Kamppeter, B A ^a   Vossmerbaeumer, U ^a   Harder, B ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Diabetic macular edema; Diabetic retinopathy; Intraocular pressure; Intravitreal steroids; Intravitreal triamcinolone acetonide

Indexed keywords

ANTIGLAUCOMA AGENT; TRIAMCINOLONE ACETONIDE; GLUCOCORTICOID;

ADULT; AGED; ARTICLE; CATARACT; CONTROLLED STUDY; DIABETIC MACULAR EDEMA; DRUG MEGADOSE; ENDOPHTHALMITIS; FEMALE; FOLLOW UP; HUMAN; INJECTION SITE INFECTION; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE; MAJOR CLINICAL STUDY; MALE; OPEN ANGLE GLAUCOMA; OPHTHALMOSCOPY; PRIORITY JOURNAL; VISUAL ACUITY; DIABETIC RETINOPATHY; DRUG EFFECT; INJECTION; MIDDLE AGED; RETINA MACULA CYSTOID EDEMA; VITREOUS BODY;

ADULT; AGED; AGED, 80 AND OVER; DIABETIC RETINOPATHY; FEMALE; FOLLOW-UP STUDIES; GLUCOCORTICOIDS; HUMANS; INJECTIONS; INTRAOCULAR PRESSURE; MACULAR EDEMA, CYSTOID; MALE; MIDDLE AGED; TRIAMCINOLONE ACETONIDE; VISUAL ACUITY; VITREOUS BODY;

EID: 33750609853     PISSN: 11206721     EISSN: None     Source Type: Journal    
DOI: 10.1177/112067210601600411     Document Type: Article

References (47)

1. Machemer R, Sugita G, Tano Y. Treatment of intraocular proliferations with intravitreal steroids. Trans Am Ophthalmol Soc 1979; 77: 171-80.
2. Machemer R. Five cases in which a depot steroid (hydrocortisone acetate and methylprednisolone acetate) was in jected into the eye. Retina 1996; 16: 166-7.
3. Jonas JB, Hayler JK, Söfker A, et al. Intravitreal injection of crystalline cortisone as adjunctive treatment of proliferative diabetic retinopathy. Am J Ophthalmol 2001; 131: 468-1.
4. Jonas JB, Söfker A. Intraocular injection of crystalline cortisone as adjunctive treatment of diabetic macular edema. Am J Ophthalmol 2001; 132: 425-7.
5. Martidis A, Duker JS, Greenberg PB, et al. Intravitreal triamcinolone for refractory diabetic macular edema. Ophthalmology 2002; 109: 920-7.
6. Jonas JB, Kreissig I, Söfker A, et al. Intravitreal injection of triamcinolone acetonide for diabetic macular edema. Arch Ophthalmol 2003; 121: 57-61.
7. Massin P, Audren F, Haouchine B, et al. Intravitreal triamcinolone acetonide for diabetic diffuse macular edema: preliminary results of a prospective controlled trial. Ophthalmology 2004; 111: 218-24.
8. Jonas JB, Degenring R, Kamppeter B, et al. Duration of the effect of intravitreal triamcinolone acetonide as treatment of diffuse diabetic macular edema. Am J Ophthalmol 2004; 138: 158-60.
9. Jonas JB, Harder B, Kamppeter B. Inter-eye difference in diabetic macular edema after unilateral intravitreal injection of triamcinolone acetonide. Am J Ophthalmol 2004; 138: 970-7.
10. Audren F, Tod M, Massin P, et al. Pharmacokinetic-pharmacodynamic modeling of the effect of triamcinolone acetonide on central macular thickness in patients with diabetic macular edema. Invest Ophthalmol Vis Sci 2004; 45: 3435-41.
11. Bakri SJ, Beer PM. Intravitreal triamcinolone injection for diabetic macular edema: a clinical and fluorescein angiographic case series. Can J Ophthalmol 2004; 39: 755-60.
12. Bandello F, Pognuz DR, Pirracchio A, et al. Intravitreal triamcinolone acetonide for florid proliferative diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol 2004; 242: 1024-7.
13. Ciardella AP, Klancnik J, Schiff W, et al. Intravitreal triamcinolone for the treatment of refractory diabetic macular edema with hard exudates: an optical coherence tomography study. Br J Ophthalmol 2004; 88: 1131-6.
14. Islam MS, Negi A, Vernon SA. Improved visual acuity and macular thickness 1 week after intravitreal triamcinolone for diabetic macular edema. Eye 2004 Dec. 3 (Epub ahead of print).
15. Karacorlu M, Ozdemir H, Karacorlu S, et al. Intravitreal triamcinolone as a primary therapy in diabetic macular edema. Eye 2005; 19: 382-6.
16. Lam DS, Chan CK, Tang EW, et al. Intravitreal triamcinolone for diabetic macular edema in Chinese patients: six-month prospective longitudinal pilot study. Clin Exp Ophthalmol 2004; 32: 569-72.
17. Negi AK, Vernon SA, Lim CS, et al. Intravitreal triamcinolone improves vision in eyes with chronic diabetic macular edema refractory to laser photocoagulation. Eye 2005; 19: 747-51.
18. Ozkiris A, Evereklioglu C, Erkilic K, et al. Intravitreal triamcinolone acetonide injection as primary treatment for diabetic macular edema. Eur J Ophthalmol 2004; 14: 543-9.
19. Sutter FK, Simpson JM, Gillies MC. Intravitreal triamcinolone for diabetic macular edema that persists after laser treatment: three-month efficacy and safety results of a prospective, randomized, double-masked, placebo-controlled clinical trial. Ophthalmology 2004; 111: 2044-9.
20. Jonas JB, Kreissig I, Degenring RF, et al. Repeated intravitreal injection of triamcinolone acetonide for diffuse diabetic macular edema. Br J Ophthalmol 2005; 89:122.
21. Jonas JB, Akkoyun I, Kreissig I, et al. Diffuse diabetic macular edema treated by intravitreal triamcinolone acetonide. A comparative non-randomized study. Br J Ophthalmol 2005; 89: 321-6.
22. Krepler K, Wagner J, Sacu S, et al. The effect of intravitreal triamcinolone on diabetic macular edema. Graefes Arch Clin Exp Ophthalmol 2005; 243: 478-81.
23. Sorensen TL, Haamann P, Villumsen J, et al. Intravitreal triamcinolone for macular edema: efficacy in relation to aetiology. Acta Ophthalmol Scand 2005; 83: 67-70.
24. Jonas JB, Martus P, Degenring RF, et al. Predictive factors for visual acuity change after intravitreal triamcinolone for diabetic macular edema. Arch Ophthalmol 2005; 123: 1338-43.
25. Spandau UH, Derse M, Schmitz-Valckenberg P, et al. Dosage-dependency of intravitreal triamcinolone acetonide as treatment for diabetic macular edema. Br J Ophthalmol 2005; 89: 999-1003
26. Spandau UH, Derse M, Schmitz-Valckenberg P, et al. Measurement of triamcinolone acetonide concentration after filtering of solvent agent. Am J Ophthalmol 2005; 139: 712-3.
27. Jonas JB, Kreissig I, Degenring RF. Intravitreal triamcinolone acetonide for treatment of intraocular proliferative, exudative and angiogenic diseases. Prog Retin Eye Res 2005; 5: 587-611.
28. Jonas JB. Concentration of intravitreally applicated triamcinolone acetonide in aqueous humour. Br J Ophthalmol 2002; 86: 1066.
29. Jonas JB. Intraocular availability of triamcinolone acetonide after intravitreal injection. Am J Ophthalmol 2004; 137: 560-2.
30. Beer PM, Bakri SJ, Singh RJ, Liu W, Peters GB 3rd, Miller M. Intraocular concentration and pharmacokinetics of triamcinolone acetonide after a single intravitreal injection. Ophthalmology 2003; 110: 681-6.
31. Wingate RJ, Beaumont PE. Intravitreal triamcinolone and elevated intraocular pressure. Aust NZ J Ophthalmol 1999; 27: 431-2.
32. Benz MS, Murray TG, Dubovy SR, et al. Endophthalmitis caused by Mycobacterium chelonae abscessus after intravitreal injection of triamcinolone. Arch Ophthalmol 2003; 121: 271-3.
33. Gillies MC, Simpson JM, Billson FA, et al. Safety of an intravitreal injection of triamcinolone: results from a randomized clinical trial. Arch Ophthalmol 2004; 122: 336-40.
34. Gillies M, Kuzniarz M, Craig J, et al. Intravitreal triamcinolone-induced elevated intraocular pressure is associated with the development of posterior subcapsular cataract. Ophthalmology 2005; 112: 139-43.
35. Degenring RF, Jonas JB. Serum levels of triamcinolone acetonide after intravitreal injection. Am J Ophthalmol 2004; 137: 1142-3.
36. Early Treatment Diabetic Retinopathy Study Research Group. Early photocoagulation for diabetic retinopathy. ETDRS report number 9. Ophthalmology 1991; 98: 766-85.
37. McDonald HR, Schatz H. Grid photocoagulation for diffuse macular edema. Retina 1985; 5: 65-72.
38. Lee CM, Olk RJ. Modified grid laser photocoagulation for diffuse diabetic macular edema. Long-term visual results. Ophthalmology 1991; 98: 1594-602.
39. Jonas JB, Degenring RF, Kreissig I, Akkoyun I, Kamppeter BA. Intraocular pressure elevation after intravitreal triamcinolone acetonide injection. Ophthalmology 2005; 112: 593-8.
40. Al-Haddad CE, Jurdi FA, Bashshur ZF. Intravitreal triamcinolone acetonide for the management of diabetic papillopathy. Am J Ophthalmol 2004; 137: 1151-3.
41. Habib MS, Cannon PS, Steel DH. The combination of intravitreal triamcinolone and phacoemulsification surgery in patients with diabetic foveal edema and cataract. BMC Ophthalmol 2005; 5: 15.
42. Smithen LM, Ober MD, Maranan L, et al. Intravitreal triamcinolone acetonide and intraocular pressure. Am J Ophthalmol 2004; 138: 740-3.
43. Park HY, Yi K, Kim HK. Intraocular pressure elevation after intravitreal triamcinolone acetonide injection. Kor J Ophthalmol 2005; 19: 122-7.
44. Jaffe GJ, McCallum RM, Branchaud B, et al. Long-term follow-up results of a pilot trial of a fluocinolone acetonide implant to treat posterior uveitis. Ophthalmology 2005; 112: 1192-8.
45. Jonas JB, Degenring RF, Vossmerbaeumer U, et al. Frequency of cataract surgery after intravitreal injection of high-dosage triamcinolone acetonide. Eur J Ophthalmol 2005; 15: 462-4.
46. Westfall AC, Osborn A, Kuhl D, et al. Acute endophthalmitis incidence: intravitreal triamcinolone. Arch Ophthalmol 2005; 123: 1075-7.
47. Avci R, Kaderli B. Intravitreal triamcinolone injection for chronic diabetic macular edema with severe hard exudates. Graefes Arch Clin Exp Ophthalmol 2006; 244: 28-35.